Navigation Links
MAP Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Date:1/4/2011

MOUNTAIN VIEW, Calif., Jan. 4, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the company will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 8:00 a.m. PT in San Francisco.

A live webcast of the presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay will also be available within 24 hours for seven days following the presentation.

About MAP Pharmaceuticals MAP Pharmaceuticals is an emerging biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX™ orally inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com. CONTACT: Alex BowieWCG(212) 301-7201abowie@wcgworld.com
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Jan. 18, 2017  Aprima Medical Software, a ... practice management (PM) and revenue cycle management (RCM) ... of a former reseller Healthcare Data Solutions (HDS) ... agreement, Aprima will assume full support for HDS,s ... medical practices across 15 states. Financial terms were ...
(Date:1/18/2017)... -- Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering. ... Vital signs monitoring market ... $5,491 million by 2022, growing at a CAGR of 5.8% from 2016 ... the leading regional market in global vital signs monitoring devices industry. The ...
(Date:1/18/2017)... , Jan. 18, 2017  Adaptive Sound Technologies, Inc. (ASTI), ... new partnership with Hyatt Place Nashville/Downtown to deliver the ... LectroFan sleep therapy machines in over two hundred of ... most important parts of having a great stay is ... of Hyatt Place Nashville/Downtown. "We,re pleased to be able ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... St. Catherine’s Village announced that ... Center is a skilled nursing facility on the grounds of the St. Catherine’s Village ... recently was voted the best nursing home in Mississippi for the second year in ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... taken in the 2017 Spring Create Real Impact contest from Impact Teen Drivers ... 17 at http://www.createrealimpact.com . , Educational grants totaling $15,000 will be ...
(Date:1/19/2017)... ... January 18, 2017 , ... The CHP suggests that California drivers ... storm by slowing down and increasing the space between themselves and other vehicles, according ... car accident attorney Raymond R. Hassanlou notes that, rain or shine, drivers should always ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Connecticut Dermatology Group ... Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background ... , “It is with considerable pleasure to welcome back Dr. Kim to the CDG ...
(Date:1/19/2017)... ... ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today that it ... years SFI has been recognized as the world’s leader in Intelligent Sales Outsourcing Solutions. ... market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, Ariello, Inc. ...
Breaking Medicine News(10 mins):